Page 3 - Early Phase News Today

Press Release Stockholm, Sweden, November 2, 2023   Mendus announces multiple abstracts to be presented at ASH 2023 including oral presentation on ADVANCE II survival data Three abstracts...

Smart Immune to Present Details of Pioneering Clinical Study at the American Society of Hematology (ASH) Annual Meeting 2023PARIS, France, 02 Nove...

-- Oral Presentation Highlights Latest Clinical Findings from First Global, In-Human Phase 1/2 Dose-Escalation Study of Anti-CD7 Off-the-Shelf Allogeneic CAR-T Cell Therapy, WU-CART-007, in Hard-to-Treat T-ALL/LBL Patients

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced the acceptance of a poster presentation at the...

First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...

DelveInsight’s, “Prostate Cancer Pipeline Insight 2023” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Prostate Cancer pipeline landscape. It covers the

Players who pre-ordered PAYDAY 3’s Gold Edition can start playing the game 3 days before release.

Angola’s Plan to Improve Oil Industry Performance is Already Yielding Fruit with Fast-Tracking Sustainable Oil Development (By NJ Ayuk)

By NJ Ayuk, Executive Chairman, African Energy Chamber (www.EnergyChamber.org). Angola has been in the petroleum business for a long...

The country’s crude yields peaked in 2008 at slightly less than 2 MMbpd and now stand at around 1.10-1.15 MMbpd.